Tadej Avcin

📢 PReS is now on social media! Follow us and be the first to know about our initiatives and ongoing activities! Let’s grow and strengthen our community together. #PReS #PaediatricRheumatology #StayConnected

Wonderful and stimulating mini symposium of the Central European pediatric rheumatology group was a great start of #CECR2024 congress. Ped rheum sessions are for the first time part of the main #CECR congress programme.🤝🇦🇹🇭🇷🇨🇿🇹🇯🇮🇹🇸🇰🇸🇮

📢Exciting news! Our paper on core & expanded datasets for cSLE research is out @ARD_BMJ! 🌍 Huge global collaboration supported by @carrainc & PReS/@PReSLupusWP. ⏲️Time to start collecting these data to collaborate & make a difference worldwide! 🤝 ard.bmj.com/cgi/rapidpdf/a….

Selfi photo of a wonderful group of the EU Interreg project #CONCERTO🤝🙏🇮🇹🇸🇮

20.09.24 - 11 a.m @ Faculty of Medicine, University of Ljubljana 🇮🇹 si terrà il meeting annuale del progetto CONCERTO. 🇸🇮 potekalo letno srečanje projekta CONCERTO. 🇬🇧 the annual meeting of the CONCERTO project will be held. #InterregITASLO @InterregITASLO #Interregitasloconcerto

🇮🇹 Ecco il programma del meeting annuale che si terrà il 20.09: ita-slo.eu/it/notizie-ed-… 🇸🇮 Tukaj je program letnega srečanja, ki bo potekalo 20.09: ita-slo.eu/sl/novice-in-d… 🇬🇧Here is the programme for the annual meeting to be held on 20.09: ita-slo.eu/en/news-and-ev… #InterregITASLO

Congratulations to all the winners of the best abstracts award at the #PReS2024 Young Investigators Meeting

Welcome to the 25th anniversary of #PReS in Gothenburg!

Very pleased to announce launching of PReS and Neutrolis partnership in developing target therapy in patients w/ DNASE1L3 def. Please register if interested neutrolis.com/patients

NEW SERIES on #pregnancy in rheumatic disease calls for a reconsideration of therapeutic decisions to optimise the safe and effective use of DMARDs, and proposes solutions to the challenges of studies in pregnancy thelancet.com/series/pregnan… #EULAR2024

🌟 B-cell depletion in autoimmune diseases 🔷 Review 🔷Current therapeutic strategies to deplete B cells in order to ameliorate or potentially even cure autoimmune disease 🔗 bit.ly/3RwAWBx

Serum TNF-alpha levels do not correlate with JIA disease activity in patients treated with TNF inhibitors. These drugs extend TNF-alpha half-life and serum levels of TNF-alpha do not reflect inflammatory activity in the joints rdcu.be/dIJ33

Thank you @AlexandreBelot for outstanding grand round and stimulating research discussions during the visiting professorship at the Univ. Children's Hospital Ljubljana 🇨🇵🇸🇮👏🤝

Proud of my colleague Natasa Toplak showing safety data of prospective MMR/MMRV vaccine booster study in patients on biologics #Autoimmunity2024

@MartaMartamosca @ern_reconnet Many thanks, Marta for your kind support of the pediatric rheumatology community🙏

And now Tadej Avcin presenting challenges in pediatric APS @ern_reconnet

The CABC conference is also and exemplary model of collaboration between patients and physicians. Hearing and learning from touching testimonials from patients and parents🙏

Amazing program and stimulating discussions at the UCAN Childhood arthritis & beyond conference in Toronto🇨🇦 🇳🇱 We are slowly getting closer to the biology based taxonomy of JIA. Very pleased to be invited and meeting old and new friends from SickKids!

Please check the new HORIZON-MSCA PhD Position in Immunology at the UCH Ljubljana focusing on genomics and single-cell transcriptomics in JIA 👉euraxess.ec.europa.eu/jobs/212540 Deadline to apply 8th May 2024